These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3275333)

  • 21. Intensive multi-drug post-operative chemotherapy for high risk stage II breast cancer.
    Shetty PA; D'Souza LJ; Shinde SR; Jussawalla DJ
    Indian J Cancer; 1983; 20(4):211-4. PubMed ID: 6676170
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjuvant chemotherapy with cyclophosphamide methotrexate and 5-fluorouracil (CMF) in stage II breast cancer in Indian patients.
    Shetty PA; Sarda PK; Majumdar AT; Pai VR; Shinde SR; D'Souza LJ; Pinto JM; Jussawalla DJ
    Indian J Cancer; 1985 Sep; 22(3):239-44. PubMed ID: 3843327
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience with an adjuvant chemotherapy program in stage II breast cancer].
    Morelli M; Valle M; Balducci D; Nardi M; Serafini D; Bontempi G
    Minerva Ginecol; 1984 Oct; 36(10):619-22. PubMed ID: 6527815
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinico-statistical features of breast pathology in old age].
    Melita P; Gorgone S; Belnome NA; Palmeri R; Pergolizzi FP; Liotta G
    Chir Ital; 1984 Oct; 36(5):887-95. PubMed ID: 6545147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Brown RJ; Davidson NE
    Semin Oncol; 2006 Dec; 33(6):657-63. PubMed ID: 17145345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local management in primary breast cancer. Our experience of 331 cases.
    Appelqvist P; Salmo M; Leivonen M; Kalima T; Saario I; Tolppanen EM
    Strahlenther Onkol; 1987 Oct; 163(10):643-7. PubMed ID: 3672311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotherapy of primary and metastasizing breast cancer].
    Hofmann V; Martz G
    Gynakol Rundsch; 1984; 24 Suppl 1():78-86. PubMed ID: 6394442
    [No Abstract]   [Full Text] [Related]  

  • 28. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
    J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response.
    Cameron DA; Gregory WM; Bowman A; Anderson ED; Levack P; Forouhi P; Leonard RC
    Br J Cancer; 2000 Jul; 83(1):98-103. PubMed ID: 10883676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose therapy for the treatment of breast cancer: evaluation of effect of regimen on outcome.
    Fields KK; Perkins JB; Partyka JS; Elfenbein GJ
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S30-3. PubMed ID: 8899167
    [No Abstract]   [Full Text] [Related]  

  • 32. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapeutic results obtained with aminoglutethimide in advanced-stage breast cancer. Factors predictive of a response].
    Paridaens RJ; Arrigo C; Heuson JC
    Acta Clin Belg Suppl; 1986; 11():18-28. PubMed ID: 3459320
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic update on cancer of the breast].
    Awada A; Leo AD; Piccart MJ
    Bull Cancer; 2000 Jan; 87(1):49-62. PubMed ID: 10673632
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapy studies of the Austrian Breast Cancer Group (ABC)].
    Jakesz R; Hausmaninger H; Samonigg H; Kubista E; Haider K; Mlineritsch B; Schmid M; Tausch C; Reiner G; Renner K; Stierer M; Jatzko G; Hofbauer F; Fridrik M; Schennach W; Sevelda P; Dadak C; Haid A; Scholz R; Lenzhofer P; Steindorfer P; Berger A; Mischinger HJ
    Zentralbl Chir; 1998; 123 Suppl 5():28-32. PubMed ID: 10063568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox.
    Mehta RS
    J Clin Oncol; 2008 Jul; 26(19):3286-8; author reply 3288. PubMed ID: 18591566
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
    Huang EH; Tucker SL; Strom EA; McNeese MD; Kuerer HM; Hortobagyi GN; Buzdar AU; Valero V; Perkins GH; Schechter NR; Hunt KK; Sahin AA; Buchholz TA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):351-7. PubMed ID: 15890574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology].
    Bontenbal M; Nortier JW; Beex LV; Bakker P; Hupperets PS; Nooij MA; van Veelen H; Vreugdenhil G; Richel DJ; Blijham GH
    Ned Tijdschr Geneeskd; 2000 May; 144(21):984-9. PubMed ID: 10858788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of adjuvant systemic therapy in organ preserving treatment of pT1-2N0M0 breast cancer].
    Semiglazov VF; Kanaev SV; Bugrova IL; Vlasov AN
    Vopr Onkol; 1999; 45(5):516-9. PubMed ID: 10629708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
    ; Basser RL; O'Neill A; Martinelli G; Green MD; Peccatori F; Cinieri S; Coates AS; Gelber RD; Aebi S; Castiglione-Gertsch M; Viale G; Price KN; Goldhirsch A
    J Clin Oncol; 2006 Jan; 24(3):370-8. PubMed ID: 16421418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.